Arkema S Profile

USD 0  0.00%

Arkema S Summary

Arkema S A (ARKAF) is traded on OTC Market in USA. It is located in 420 rue d'Estienne d'Orves and employs 20,000 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.16 B. Arkema S A has 75.68 M outstanding shares. ARKEMA has accumulated about 1.5 B in cash with 1.17 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.74.
Check Arkema S Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 116.72HorizonTargetOdds Above 116.72
32.38%30 days 116.72 67.34%
Based on normal probability distribution, the odds of Arkema S to move above current price in 30 days from now is about 67.34% (This Arkema S A probability density function shows the probability of Arkema S Stock to fall within a particular range of prices over 30 days) .

Top Holders

Arkema S A Risk Profiles

Key Fundamentals

Arkema S Against Markets

Current Ratings

Arkema S 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Arkema S A are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Its High Performance Materials segment offers adhesives and sealants for industry, hygiene, construction, and consumer products and specialty polyamides for automotive, aerospace, aeronautics, oil and gas, electronics, and consumer goods, as well as polyvinylidene fluoride for chemical engineering, paints and anti-corrosive coatings, oil and gas extraction, photovoltaic panels, lithium-ion batteries, and water treatment membranes. The company was incorporated in 2003 and is headquartered in Colombes, France. Arkema S is traded on OTC Market in USA. more
NameArkema S A
ChairmanThierry HenaffView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address420 rue d'Estienne d'Orves
ExchangeOTC Market
SectorBasic Materials
33 1 49 00 80 80
CurrencyUSD - US Dollar

Arkema S Corporate Directors

Patrice Breant Director - Shareholder Employees Representative, Ph.D
Victoire Margerie Independent Director, Ph.D
Marc Pandraud Independent Director
Check also Trending Equities. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.